GLMD icon

Galmed Pharmaceuticals
GLMD

14 hedge funds and large institutions have $102K invested in Galmed Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$81.1K
2
+$34K
3
+$34

Top Sellers

1
-$53.8K
2
-$42.7K
3
-$19K
4
UBS Group
UBS Group
Switzerland
-$9.54K
5
SS
SBI Securities
Japan
-$3.37K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$71.2K
Two Sigma Investments
2
Two Sigma Investments
New York
$29.3K
UBS Group
3
UBS Group
Switzerland
$1.33K
Morgan Stanley
4
Morgan Stanley
New York
$135
WANY
5
Wealthspire Advisors (New York)
New York
$29
SS
6
SBI Securities
Japan
$22
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$19
Wells Fargo
8
Wells Fargo
California
$12
Osaic Holdings
9
Osaic Holdings
Arizona
$6
TWC
10
TD Waterhouse Canada
Ontario, Canada
$3
AF
11
Allworth Financial
California
$3
EWP
12
Elevation Wealth Partners
California
$2
DWM
13
Dogwood Wealth Management
Kansas
$1
SSA
14
Schonfeld Strategic Advisors
New York
–
Cambridge Investment Research Advisors
15
Cambridge Investment Research Advisors
Iowa
–
PWA
16
Physician Wealth Advisors
Utah
–
Raymond James Financial
17
Raymond James Financial
Florida
–